第3届圣加仑EORTC胃肠道肿瘤会议:胰腺癌初始治疗争议问题的共识推荐
第3届圣加仑会议2016年以胰腺癌初始治疗为主题,多学科专家组系统回顾证据并讨论争议问题。会议确认根治性切除后辅助化疗是唯一有治愈机会的循证治疗,界定了可切除与不可切除(局部晚期)分类,接受临界可切除概念,并推荐R0切除后辅助化疗、R1切除后辅助化疗为合理标准治疗。
要点
- 根治性手术切除后辅助化疗是唯一有治愈机会的循证治疗。
- 初始分期应将局限期肿瘤分为可切除或不可切除(即局部晚期胰腺癌)。
- 专家组一致投票推荐R0切除后使用辅助化疗,并认为R1切除后辅助化疗为合理标准治疗。
核心结论
- 根治性手术切除后辅助化疗是唯一有治愈机会的循证治疗。
- 临界可切除肿瘤概念被专家组普遍接受,可作为选择患者接受术前治疗的依据,但其对治疗策略的当前影响远未明确。
研究设计与样本
- 第3届圣加仑会议(2016年)以胰腺癌初始治疗为主题,由多学科专家组在主持的共识会议中回顾当前证据并讨论争议问题。
- 本文报告专家组的关键推荐。
主要发现
- 初始分期应将局限期肿瘤分为可切除或不可切除(即局部晚期胰腺癌),两类之间存在大的灰色地带即临界可切除。
- 临界可切除肿瘤的定义因分类系统侧重技术障碍(如血管切除的可行性)或肿瘤学结局(如预测R1切除和/或隐匿转移的风险)而异。
- 专家组讨论聚焦于影像学标准及术前腹腔镜检查的价值。
- 胆道引流指征尤其见于新辅助治疗前。
- 专家组一致投票推荐R0切除后使用辅助化疗,并认为R1切除后辅助化疗为合理标准治疗,尽管最佳病理评估及R0/R1定义仍在讨论中。
关键数值与推荐
- 专家组一致投票推荐R0切除后使用辅助化疗。
- 专家组认为R1切除后辅助化疗为合理标准治疗。
- 胆道引流指征尤其见于新辅助治疗前。
临床怎么用
- 初始分期应将局限期肿瘤分类为可切除或不可切除(即局部晚期胰腺癌)。
- 临界可切除概念可作为选择患者接受术前治疗的依据。
- R0切除后使用辅助化疗,R1切除后辅助化疗为合理标准治疗。
局限性
- 临界可切除肿瘤的定义因分类系统而异。
- 最佳病理评估及R0/R1定义仍在讨论中。
- 临界可切除概念对治疗策略的当前影响远未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The primary treatment of pancreatic cancer was the topic of the 3rd St. Gallen Conference 2016. A multidisciplinary panel reviewed the current evidence and discussed controversial issues in a moderated consensus session. Here we report on the key expert recommendations. It was generally accepted that radical surgical resection followed by adjuvant chemotherapy offers the only evidence-based treatment with a chance for cure. Initial staging should classify localised tumours as resectable or unresectable (i.e. locally advanced pancreatic cancer) although there remains a large grey-zone of potentially resectable disease between these two categories which has recently been named as borderline resectable, a concept which was generally accepted by the panel members. However, the definition of these borderline-resectable (BR) tumours varies between classifications due to their focus on either (i) technical hurdles (e.g. the feasibility of vascular resection) or (ii) oncological outcome (e.g. predicting the risk of a R1 resection and/or occult metastases). The resulting expert discussion focussed on imaging standards as well as the value of pretherapeutic laparoscopy. Indications for biliary drainage were seen especially before neoadjuvant therapy. Following standard resection, the panel unanimously voted for the use of adjuvant chemotherapy after R0 resection and considered it as a reasonable standard of care after R1 resection, even though the optimal pathologic evaluation and the definition of R0/R1 was the issue of an ongoing debate. The general concept of BR tumours was considered as a good basis to select patients for preoperative therapy, albeit its current impact on the therapeutic strategy was far less clear. Main focus of the conference was to discuss the limits of surgical resection and to identify ways to standardise procedures and to improve curative outcome, including adjuvant and perioperative treatment.
引用
- Lutz MP, Zalcberg JR, Ducreux M, et al. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. Eur J Cancer. 2017. PMID: 28460245. doi:10.1016/j.ejca.2017.03.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。